Rowan develops ML-powered computational tools that combine rigorous physics-based calculations with modern AI algorithms to accelerate accurate molecular simulation. The platform includes workflows for predicting pKa values using AIMNet2, and a conformer-finding approach that generates fast low-level conformers then scores them with a more accurate final method. Rowan also builds custom scientific solutions for companies tailored to specific problems and domains. The company is led by CEO and Founder Corin Wagen and is based in Boston, MA. Rowan raised $2.1M in pre-seed funding and intends to use the proceeds to expand operations and development efforts.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Dec 2024